510(k) Report

FDA product code · Cardiovascular

Transcatheter Septal Occluder

MLVClass IIIPMA required5 decisions since 200113 recalls

5 FDA decisions since 2001. 13 recalls name this code, 0 of them Class I.

Approved PMA: P000039

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of MLV at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · MLV

8in 2025

2007: 52008: 92009: 112010: 62011: 132012: 92013: 52014: 72015: 52016: 172017: 132018: 142019: 272020: 212021: 142022: 112023: 32024: 162025: 82026 (partial year): 6
2007high 27 (2019) · low 3 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MLV

Too few MLV 510(k)s in any year since 2007 to give a median.

Recalls per year · MLV

2in 2022

2021: 92022: 2
2007high 9 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MLV

766in 2025

2007: 1032008: 1782009: 1872010: 1862011: 2012012: 1892013: 1342014: 1032015: 1332016: 1232017: 1402018: 2122019: 4062020: 4072021: 4872022: 5042023: 6722024: 8432025: 766
2007high 843 (2024) · low 103 (2007)2025

MAUDE reports naming product code MLV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075—0103
20089—0178
200911—0187
20106—0186
201113—0201
20129—0189
20135—0134
20147—0103
20155—0133
201617—0123
201713—0140
201814—0212
201927—0406
202021—0407
202114—9487
202211—2504
20233—0672
202416—0843
20258—0766
20266—0—
FIG. 1 — MLV by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in MLV? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report